Dr. Laren Dao-Wei Tan, MD

Dr. Tan practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.

Dr. Tan's NPI, 1821230467, was assigned on March 27, 2009. Dr. Tan graduated from Loma Linda University School Of Medicine in 2009. Dr. Tan holds California license A113182.

Dr. Tan's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.

Dr. Tan's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tan practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Tan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Tan is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Tan is licensed in California.

CMS data shows 506 Medicare services from Dr. Tan across 7 procedure codes in 2024, for 171 Medicare patients. Medicare paid $53,731 for them.

CMS counts 171 Medicare patients who saw Dr. Tan in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 51% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tan's median patient age at 68, with 58% women.

In 2024, Dr. Tan wrote 1,632 Medicare Part D claims for 169 patients. CMS names the drug for 1,443 of them, across 24 drugs with 11 or more claims each, at $1,181,968 in total drug cost. In 2023, CMS named 1,972 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Tan for performance year 2024, reported as part of a group. Dr. Tan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tan as offering telehealth.

Dmand AI links 46 papers to Dr. Tan, published from 2009 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Asthma, Anti-Asthmatic Agents and Biological Products. Dr. Tan has published most often in J Asthma Allergy. Dr. Tan's most frequent co-authors are Samuel Louie, MD, David Baylink, MD and Nicholas J. Kenyon, MD.

Dmand AI links Dr. Tan to 2 clinical trials. Conditions studied include Respiratory Insufficiency and Respiration Disorders. Loma Linda University sponsors the most, 2.

CMS Open Payments shows 370 general payments to Dr. Tan from 10 drug and device companies from 2016 to 2022. Speaker and faculty fees make up the largest share, 58% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $112,146.

Dmand AI lists 5 awards for Dr. Tan, most recently Benjamin B. Davis Award in 2015.

Dr. Tan graduated from Loma Linda University School Of Medicine in 2009.

Dr. Tan is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.